- Home
- IDYA vs KYN Comparison
IDYA vs KYN Comparison
Compare IDYA & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- KYN
- Stock Information
- Founded
- IDYA 2015
- KYN 2004
- Country
- IDYA United States
- KYN United States
- Employees
- IDYA N/A
- KYN N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- KYN Finance/Investors Services
- Sector
- IDYA Health Care
- KYN Finance
- Exchange
- IDYA Nasdaq
- KYN Nasdaq
- Market Cap
- IDYA 2.0B
- KYN 2.2B
- IPO Year
- IDYA 2019
- KYN N/A
- Fundamental
- Price
- IDYA $17.05
- KYN $12.90
- Analyst Decision
- IDYA Strong Buy
- KYN
- Analyst Count
- IDYA 13
- KYN 0
- Target Price
- IDYA $53.58
- KYN N/A
- AVG Volume (30 Days)
- IDYA 887.8K
- KYN 561.5K
- Earning Date
- IDYA 05-06-2025
- KYN 01-01-0001
- Dividend Yield
- IDYA N/A
- KYN 8.99%
- EPS Growth
- IDYA N/A
- KYN N/A
- EPS
- IDYA N/A
- KYN 0.71
- Revenue
- IDYA $7,000,000.00
- KYN N/A
- Revenue This Year
- IDYA $89.14
- KYN N/A
- Revenue Next Year
- IDYA $291.34
- KYN N/A
- P/E Ratio
- IDYA N/A
- KYN $13.79
- Revenue Growth
- IDYA N/A
- KYN N/A
- 52 Week Low
- IDYA $16.88
- KYN $7.84
- 52 Week High
- IDYA $44.42
- KYN $9.88
- Technical
- Relative Strength Index (RSI)
- IDYA 31.80
- KYN 56.85
- Support Level
- IDYA $17.05
- KYN $11.89
- Resistance Level
- IDYA $18.90
- KYN $13.05
- Average True Range (ATR)
- IDYA 0.91
- KYN 0.21
- MACD
- IDYA 0.01
- KYN 0.07
- Stochastic Oscillator
- IDYA 6.27
- KYN 85.44
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.